Subscribe for free to our flagship newsletter, CDR: This Week in Retail, for news and insights from the voice of retail pharmacy.

Skip to content

Camber releases Phenylephrine Hydrochloride Injection, USP

Phenylephrine Hydrochloride Injection, USP is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.

PISCATAWAY, N.J. –Camber Pharmaceuticals announces the addition of Phenylephrine Hydrochloride Injection, USP to their portfolio.

Phenylephrine Hydrochloride Injection, USP is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.

Phenylephrine Hydrochloride Injection, USP are available in:

  • 10 mg/mL | 25 x 1 mL Single-Dose Vials
  • 50 mg/5 mL (10 mg/mL) | 10 x 5 mL Vials
  • 100 mg/10 mL (10 mg/mL) | 10 mL Vial

 To find out more information on Phenylephrine Injection, USP, visit: www.camberpharma.com/phenylephrine

Comments

Latest